牛牛AI助理已提取核心訊息
Gregory M Sullivan, the Chief Medical Officer of Tonix Pharmaceuticals Holding Corp. (TNXP), was reported to have engaged in a transaction involving the company's stock on February 27, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. As a result, the number of shares Sullivan holds after the transaction remains unknown.
Gregory M Sullivan, the Chief Medical Officer of Tonix Pharmaceuticals Holding Corp. (TNXP), was reported to have engaged in a transaction involving the company's stock on February 27, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. As a result, the number of shares Sullivan holds after the transaction remains unknown.
據報道，Tonix Pharmicals Holding Corp.（TNXP）首席醫療官格雷戈裏·沙利文於2024年2月27日參與了一項涉及該公司股票的交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。也沒有提供交易的操作類型和狀態。因此，沙利文在交易後持有的股票數量仍然未知。
據報道，Tonix Pharmicals Holding Corp.（TNXP）首席醫療官格雷戈裏·沙利文於2024年2月27日參與了一項涉及該公司股票的交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。也沒有提供交易的操作類型和狀態。因此，沙利文在交易後持有的股票數量仍然未知。
有用
沒用